Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Granulocyte Macrophage Colony Stimulating Factor Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Granulocyte Macrophage Colony Stimulating Factor Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 CG-0070
      • 1.3.3 Gimsilumab
      • 1.3.4 GSK-3196165
      • 1.3.5 Lenzilumab
      • 1.3.6 MGN-1601
      • 1.3.7 Others
    • 1.4 Market Segment by Application
      • 1.4.1 Global Granulocyte Macrophage Colony Stimulating Factor Market Share by Application (2019-2025)
      • 1.4.2 Solid Tumor
      • 1.4.3 Lymphoma
      • 1.4.4 Kidney Cancer
      • 1.4.5 Lung Disease
      • 1.4.6 Others
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Granulocyte Macrophage Colony Stimulating Factor Market Size
      • 2.1.1 Global Granulocyte Macrophage Colony Stimulating Factor Revenue 2014-2025
      • 2.1.2 Global Granulocyte Macrophage Colony Stimulating Factor Sales 2014-2025
    • 2.2 Granulocyte Macrophage Colony Stimulating Factor Growth Rate by Regions
      • 2.2.1 Global Granulocyte Macrophage Colony Stimulating Factor Sales by Regions 2014-2019
      • 2.2.2 Global Granulocyte Macrophage Colony Stimulating Factor Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Granulocyte Macrophage Colony Stimulating Factor Sales by Manufacturers
      • 3.1.1 Granulocyte Macrophage Colony Stimulating Factor Sales by Manufacturers 2014-2019
      • 3.1.2 Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Granulocyte Macrophage Colony Stimulating Factor Revenue by Manufacturers (2014-2019)
      • 3.2.2 Granulocyte Macrophage Colony Stimulating Factor Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Granulocyte Macrophage Colony Stimulating Factor Market Concentration Ratio (CR5 and HHI)
    • 3.3 Granulocyte Macrophage Colony Stimulating Factor Price by Manufacturers
    • 3.4 Key Manufacturers Granulocyte Macrophage Colony Stimulating Factor Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Granulocyte Macrophage Colony Stimulating Factor Market
    • 3.6 Key Manufacturers Granulocyte Macrophage Colony Stimulating Factor Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 CG-0070 Sales and Revenue (2014-2019)
      • 4.1.2 Gimsilumab Sales and Revenue (2014-2019)
      • 4.1.3 GSK-3196165 Sales and Revenue (2014-2019)
      • 4.1.4 Lenzilumab Sales and Revenue (2014-2019)
      • 4.1.5 MGN-1601 Sales and Revenue (2014-2019)
      • 4.1.6 Others Sales and Revenue (2014-2019)
    • 4.2 Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Type
    • 4.3 Global Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Type
    • 4.4 Granulocyte Macrophage Colony Stimulating Factor Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Granulocyte Macrophage Colony Stimulating Factor Sales by Application

    6 United States

    • 6.1 United States Granulocyte Macrophage Colony Stimulating Factor Breakdown Data by Company
    • 6.2 United States Granulocyte Macrophage Colony Stimulating Factor Breakdown Data by Type
    • 6.3 United States Granulocyte Macrophage Colony Stimulating Factor Breakdown Data by Application

    7 European Union

    • 7.1 European Union Granulocyte Macrophage Colony Stimulating Factor Breakdown Data by Company
    • 7.2 European Union Granulocyte Macrophage Colony Stimulating Factor Breakdown Data by Type
    • 7.3 European Union Granulocyte Macrophage Colony Stimulating Factor Breakdown Data by Application

    8 China

    • 8.1 China Granulocyte Macrophage Colony Stimulating Factor Breakdown Data by Company
    • 8.2 China Granulocyte Macrophage Colony Stimulating Factor Breakdown Data by Type
    • 8.3 China Granulocyte Macrophage Colony Stimulating Factor Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Granulocyte Macrophage Colony Stimulating Factor Breakdown Data by Company
    • 9.2 Rest of World Granulocyte Macrophage Colony Stimulating Factor Breakdown Data by Type
    • 9.3 Rest of World Granulocyte Macrophage Colony Stimulating Factor Breakdown Data by Application
    • 9.4 Rest of World Granulocyte Macrophage Colony Stimulating Factor Breakdown Data by Countries
      • 9.4.1 Rest of World Granulocyte Macrophage Colony Stimulating Factor Sales by Countries
      • 9.4.2 Rest of World Granulocyte Macrophage Colony Stimulating Factor Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 Aduro BioTech Inc
      • 10.1.1 Aduro BioTech Inc Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Granulocyte Macrophage Colony Stimulating Factor
      • 10.1.4 Granulocyte Macrophage Colony Stimulating Factor Product Introduction
      • 10.1.5 Aduro BioTech Inc Recent Development
    • 10.2 Amgen Inc
      • 10.2.1 Amgen Inc Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Granulocyte Macrophage Colony Stimulating Factor
      • 10.2.4 Granulocyte Macrophage Colony Stimulating Factor Product Introduction
      • 10.2.5 Amgen Inc Recent Development
    • 10.3 BriaCell Therapeutics Corp
      • 10.3.1 BriaCell Therapeutics Corp Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Granulocyte Macrophage Colony Stimulating Factor
      • 10.3.4 Granulocyte Macrophage Colony Stimulating Factor Product Introduction
      • 10.3.5 BriaCell Therapeutics Corp Recent Development
    • 10.4 Cold Genesys Inc
      • 10.4.1 Cold Genesys Inc Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Granulocyte Macrophage Colony Stimulating Factor
      • 10.4.4 Granulocyte Macrophage Colony Stimulating Factor Product Introduction
      • 10.4.5 Cold Genesys Inc Recent Development
    • 10.5 GlaxoSmithKline Plc
      • 10.5.1 GlaxoSmithKline Plc Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Granulocyte Macrophage Colony Stimulating Factor
      • 10.5.4 Granulocyte Macrophage Colony Stimulating Factor Product Introduction
      • 10.5.5 GlaxoSmithKline Plc Recent Development
    • 10.6 Humanigen Inc
      • 10.6.1 Humanigen Inc Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of Granulocyte Macrophage Colony Stimulating Factor
      • 10.6.4 Granulocyte Macrophage Colony Stimulating Factor Product Introduction
      • 10.6.5 Humanigen Inc Recent Development
    • 10.7 Mologen AG
      • 10.7.1 Mologen AG Company Details
      • 10.7.2 Company Description and Business Overview
      • 10.7.3 Sales, Revenue and Market Share of Granulocyte Macrophage Colony Stimulating Factor
      • 10.7.4 Granulocyte Macrophage Colony Stimulating Factor Product Introduction
      • 10.7.5 Mologen AG Recent Development
    • 10.8 Morphotek Inc
      • 10.8.1 Morphotek Inc Company Details
      • 10.8.2 Company Description and Business Overview
      • 10.8.3 Sales, Revenue and Market Share of Granulocyte Macrophage Colony Stimulating Factor
      • 10.8.4 Granulocyte Macrophage Colony Stimulating Factor Product Introduction
      • 10.8.5 Morphotek Inc Recent Development
    • 10.9 Sillajen Biotherapeutics
      • 10.9.1 Sillajen Biotherapeutics Company Details
      • 10.9.2 Company Description and Business Overview
      • 10.9.3 Sales, Revenue and Market Share of Granulocyte Macrophage Colony Stimulating Factor
      • 10.9.4 Granulocyte Macrophage Colony Stimulating Factor Product Introduction
      • 10.9.5 Sillajen Biotherapeutics Recent Development
    • 10.10 Takeda Pharmaceutical Co Ltd
      • 10.10.1 Takeda Pharmaceutical Co Ltd Company Details
      • 10.10.2 Company Description and Business Overview
      • 10.10.3 Sales, Revenue and Market Share of Granulocyte Macrophage Colony Stimulating Factor
      • 10.10.4 Granulocyte Macrophage Colony Stimulating Factor Product Introduction
      • 10.10.5 Takeda Pharmaceutical Co Ltd Recent Development

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Granulocyte Macrophage Colony Stimulating Factor Sales Channels
      • 11.2.2 Granulocyte Macrophage Colony Stimulating Factor Distributors
    • 11.3 Granulocyte Macrophage Colony Stimulating Factor Customers

    12 Market Forecast

    • 12.1 Global Granulocyte Macrophage Colony Stimulating Factor Sales and Revenue Forecast 2019-2025
    • 12.2 Global Granulocyte Macrophage Colony Stimulating Factor Sales Forecast by Type
    • 12.3 Global Granulocyte Macrophage Colony Stimulating Factor Sales Forecast by Application
    • 12.4 Granulocyte Macrophage Colony Stimulating Factor Forecast by Regions
      • 12.4.1 Global Granulocyte Macrophage Colony Stimulating Factor Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Granulocyte Macrophage Colony Stimulating Factor Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      In 2019, the market size of Granulocyte Macrophage Colony Stimulating Factor is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Granulocyte Macrophage Colony Stimulating Factor.

      This report studies the global market size of Granulocyte Macrophage Colony Stimulating Factor, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Granulocyte Macrophage Colony Stimulating Factor sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Aduro BioTech Inc
      Amgen Inc
      BriaCell Therapeutics Corp
      Cold Genesys Inc
      GlaxoSmithKline Plc
      Humanigen Inc
      Mologen AG
      Morphotek Inc
      Sillajen Biotherapeutics
      Takeda Pharmaceutical Co Ltd

      Market Segment by Product Type
      CG-0070
      Gimsilumab
      GSK-3196165
      Lenzilumab
      MGN-1601
      Others

      Market Segment by Application
      Solid Tumor
      Lymphoma
      Kidney Cancer
      Lung Disease
      Others

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Granulocyte Macrophage Colony Stimulating Factor status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Granulocyte Macrophage Colony Stimulating Factor manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Granulocyte Macrophage Colony Stimulating Factor are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now